Jason Gerberry
Stock Analyst at Bank of America Securities
(4.92)
# 211
Out of 4,596 analysts
880
Total ratings
61.3%
Success rate
20.6%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Maintained: Buy | $276 | $250.94 | +9.99% | 15 | Jul 31, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $66 → $71 | $65.31 | +8.71% | 14 | Jul 30, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $40 → $41 | $35.01 | +17.11% | 83 | Jul 30, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $90 → $93 | $51.77 | +79.64% | 47 | Jul 29, 2026 | |
| ALKS Alkermes | Reiterated: Sell | $38 | $48.99 | -22.43% | 42 | Jul 28, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $93 → $100 | $84.65 | +18.13% | 21 | Jul 28, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $263 | $256.35 | +2.59% | 13 | Jul 28, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $141 | $130.20 | +8.29% | 18 | Jul 22, 2026 | |
| LLY Eli Lilly and Company | Rated: Buy | $1,251 → $1,334 | $1,148.84 | +16.12% | 16 | Jul 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $252.86 | - | 71 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $14 | $17.56 | -20.27% | 41 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 | $25.01 | +3.96% | 12 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $626 → $613 | $517.71 | +18.41% | 20 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $217.99 | - | 29 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $58.43 | - | 8 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $59.04 | +50.75% | 21 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $20 | $19.94 | +0.30% | 16 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $79 | $84.11 | -6.08% | 19 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $41 | $53.03 | -22.69% | 35 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $35 | $11.31 | +209.46% | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $60.02 | +33.29% | 14 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $43 | $38.62 | +11.34% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.685 | +191.97% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $5.30 | +484.91% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $54.08 | - | 30 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $20.31 | +8.32% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.52 | - | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $77 | $62.67 | +22.87% | 14 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $28 | $35.24 | -20.54% | 15 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.01 | $9.65 | -27.36% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $13.55 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $1.54 | -35.06% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.50 | -25.93% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $23.86 | - | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $27.21 | +2.90% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $18.83 | -20.34% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.41 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.88 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $3.5 | $2.10 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $6.73 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $1 | $1.15 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $10.00 | n/a | 1 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $5.22 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $35.02 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $205.52 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $143.15 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $1.17 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $4.95 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.4962 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $26.41 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $10.11 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $18.32 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $47.08 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $4.23 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $166.80 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0025 | n/a | 3 | Jan 19, 2016 |
AbbVie
Jul 31, 2026
Maintained: Buy
Price Target: $276
Current: $250.94
Upside: +9.99%
Bristol-Myers Squibb Company
Jul 30, 2026
Reiterated: Buy
Price Target: $66 → $71
Current: $65.31
Upside: +8.71%
Teva Pharmaceutical Industries
Jul 30, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $35.01
Upside: +17.11%
Ionis Pharmaceuticals
Jul 29, 2026
Reiterated: Buy
Price Target: $90 → $93
Current: $51.77
Upside: +79.64%
Alkermes
Jul 28, 2026
Reiterated: Sell
Price Target: $38
Current: $48.99
Upside: -22.43%
Arrowhead Pharmaceuticals
Jul 28, 2026
Maintained: Buy
Price Target: $93 → $100
Current: $84.65
Upside: +18.13%
Johnson & Johnson
Jul 28, 2026
Reiterated: Hold
Price Target: $263
Current: $256.35
Upside: +2.59%
Merck & Co.
Jul 22, 2026
Reiterated: Buy
Price Target: $141
Current: $130.20
Upside: +8.29%
Eli Lilly and Company
Jul 10, 2026
Rated: Buy
Price Target: $1,251 → $1,334
Current: $1,148.84
Upside: +16.12%
Jazz Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $252.86
Upside: -
Jul 10, 2026
Reiterated: Sell
Price Target: $10 → $14
Current: $17.56
Upside: -20.27%
Jul 10, 2026
Rated: Hold
Price Target: $26
Current: $25.01
Upside: +3.96%
Jul 10, 2026
Reiterated: Hold
Price Target: $626 → $613
Current: $517.71
Upside: +18.41%
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $217.99
Upside: -
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $58.43
Upside: -
Jul 8, 2026
Maintained: Buy
Price Target: $89
Current: $59.04
Upside: +50.75%
Jun 29, 2026
Downgraded: Sell
Price Target: $25 → $20
Current: $19.94
Upside: +0.30%
Jun 29, 2026
Downgraded: Hold
Price Target: $79
Current: $84.11
Upside: -6.08%
Jun 22, 2026
Maintained: Sell
Price Target: $41
Current: $53.03
Upside: -22.69%
Jun 1, 2026
Maintained: Buy
Price Target: $44 → $35
Current: $11.31
Upside: +209.46%
May 29, 2026
Reiterated: Buy
Price Target: $80
Current: $60.02
Upside: +33.29%
May 21, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $38.62
Upside: +11.34%
May 14, 2026
Reiterated: Buy
Price Target: $2
Current: $0.685
Upside: +191.97%
May 12, 2026
Maintained: Buy
Price Target: $29 → $31
Current: $5.30
Upside: +484.91%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $54.08
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $22
Current: $20.31
Upside: +8.32%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $25.52
Upside: -
Mar 9, 2026
Reiterated: Buy
Price Target: $50 → $77
Current: $62.67
Upside: +22.87%
Feb 24, 2026
Reiterated: Sell
Price Target: $32 → $28
Current: $35.24
Upside: -20.54%
Feb 18, 2026
Reiterated: Sell
Price Target: $7.01
Current: $9.65
Upside: -27.36%
Feb 13, 2026
Maintained: Sell
Price Target: n/a
Current: $13.55
Upside: -
Jan 12, 2026
Maintained: Sell
Price Target: $1
Current: $1.54
Upside: -35.06%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $13.50
Upside: -25.93%
Nov 7, 2025
Maintained: Sell
Price Target: n/a
Current: $23.86
Upside: -
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $27.21
Upside: +2.90%
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $18.83
Upside: -20.34%
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $1.41
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $1.88
Upside: n/a
Aug 9, 2023
Maintained: Sell
Price Target: $4 → $3.5
Current: $2.10
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $6.73
Upside: n/a
Jan 5, 2023
Maintained: Sell
Price Target: $5 → $1
Current: $1.15
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $11
Current: $10.00
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $5.22
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $35.02
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $205.52
Upside: n/a
Aug 20, 2019
Maintained: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $143.15
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $1.17
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $4.95
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.4962
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $26.41
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $10.11
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $18.32
Upside: n/a
Aug 8, 2016
Maintained: Hold
Price Target: n/a
Current: $47.08
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $4.23
Upside: n/a
Jul 13, 2016
Maintained: Buy
Price Target: $70
Current: $166.80
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0025
Upside: n/a